Examining the Future: Niagen Bioscience's Earnings Outlook

Niagen Bioscience (NASDAQ:NAGE) is preparing to release its quarterly earnings on Wednesday, 2025-08-06. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Niagen Bioscience to report an earnings per share (EPS) of $0.01.

Anticipation surrounds Niagen Bioscience's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Past Earnings Performance

The company's EPS beat by $0.04 in the last quarter, leading to a 9.35% increase in the share price on the following day.

Here's a look at Niagen Bioscience's past performance and the resulting price change:

Quarter

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

0.02

0.02

0

-0.02

EPS Actual

0.06

0.09

0.02

0

Price Change %

9.0%

53.0%

68.0%

10.0%

Performance of Niagen Bioscience Shares

Shares of Niagen Bioscience were trading at $9.64 as of August 04. Over the last 52-week period, shares are up 250.42%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

Analyst Opinions on Niagen Bioscience

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Niagen Bioscience.

With 3 analyst ratings, Niagen Bioscience has a consensus rating of Buy. The average one-year ...